Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4222385Aexternal-prioritypatent/DE4222385A1/de
Priority claimed from DE19924227892external-prioritypatent/DE4227892A1/de
Priority claimed from DE19934305063external-prioritypatent/DE4305063A1/de
Priority claimed from PCT/EP1993/001728external-prioritypatent/WO1994001553A1/de
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of NO940797LpublicationCriticalpatent/NO940797L/no
Publication of NO940797D0publicationCriticalpatent/NO940797D0/no
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Oppfinnelsen beskriver fremstillingen av polypeptider med bindingsaktiviteter overfor reseptorer i den "lille rhino- virusresptorgruppe", fremgangsmåter for fremstilling av pep- tidene, anvendelsen av disse og DNA som koder for peptidene.
NO940797A1992-07-081994-03-07Reseptorderivater som har bindingseter for human-rhinovirus
NO940797D0
(no)
Substituerede dihydrodibenzo(b,f)azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle lidelser i centralnervesystemet og farmaceutiske sammensætninger indeholdende disse
Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes